Correlation Between Valneva SE and Soleno Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Soleno Therapeutics, you can compare the effects of market volatilities on Valneva SE and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Soleno Therapeutics.

Diversification Opportunities for Valneva SE and Soleno Therapeutics

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Valneva and Soleno is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and Soleno Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Soleno Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.12 times less risky than Soleno Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Soleno Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  2,315  in Soleno Therapeutics on August 25, 2024 and sell it today you would earn a total of  3,463  from holding Soleno Therapeutics or generate 149.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.63%
ValuesDaily Returns

Valneva SE ADR  vs.  Soleno Therapeutics

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Soleno Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and Soleno Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Soleno Therapeutics

The main advantage of trading using opposite Valneva SE and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.
The idea behind Valneva SE ADR and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk